Zallanz 30 mg 30 capsules

Tradename

Zallanz

Compound:

Each capsule contains:

Lansoprazole 30 mg

Auxiliary components:

mannitol, calcium carmellose, magnesium carbonate, disubstituted sodium phosphate, sodium lauryl sulfate, povidone (K-30), polysorbate, hypromellose, macrogol, titanium dioxide, sodium hydroxide, gelatin.

Properties

Antiulcer agent. Specific inhibitor of H+-K+-ATPase. Acting in the final phase of hydrochloric acid secretion in the stomach, lansoprazole reduces acid production, regardless of the nature of the stimulating factor.

Possessing high lipophilicity, it easily penetrates into the parietal cells of the stomach, concentrates in them and has a cytoprotective effect, increasing oxygenation of the gastric mucosa and increasing secretion.

Indications

Duodenal ulcer in the acute phase, gastric ulcer in the acute phase, reflux esophagitis, Zollinger-Ellison syndrome; eradication of Helicobacter pylori in the gastric mucosa in infected patients with peptic ulcer of the stomach and duodenum.

Dosage and administration

The optimal dosage regimen is determined by the doctor. Compliance of the dosage form of a particular drug with indications for use and dosing regimen should be strictly observed.

Take orally 30 mg 1-2 times / day. The duration of use depends on the indications and the treatment regimen.

Contraindications

Pregnancy, lactation (breastfeeding), hypersensitivity to lansoprazole.

Precautionary measures:

Use with caution in patients with severe hepatic impairment.

Side effects

From the digestive system: diarrhea, abdominal pain; rarely — constipation.

From the side of the central nervous system: headaches; rarely — dizziness, drowsiness; in some cases — depression.

From the respiratory system: rarely — pharyngitis, rhinitis.